1. Salmans Sandra. Depression: Questions You Have –
Answers You Need, People's Medical Society,
1997, ISBN 978-1-882606-14-6.
2. Jump up^ "NIMH· Depression". nimh.nih.gov.
Retrieved 15 October 2012.
3. L. E. Schechter, R. H. Ring, C. E. Beyer, Z. A. Hughes,
X. Khawaja, J. E. Malberg, S. R. Lipson. Innovative
approaches for the development of antidepressant
drugs: current and future strategies, NeuroRx 2:
590-611 (2005).
4. WHO. Investing in mental health, World Health
Organization, Geneva, 2003.
5. WHO. Conquering Depression, World Health
Organization: New Delhi, 2001.
6. P. V. Tran, F. P. Bymaster, R. K. McNamara, W. Z.
Potter. Dual monoamine modulation for improved
treatment of major depressive disorder, J Clin
Psychopharmacol 23:78-86 (2003).
7. J. T. Coyle, R. S. Duman. Finding the intracellular
signaling pathways affected by mood disorders
treatments, Neuron 38: 157-160 (2003).
8. F. A. Henn, B. Vollmayr. Neurogenesis and
depression: etiology or epiphenomenon? Biol
Psychiatry 56: 146-150 (2004).
9. H. P. Rang, M. M. Dale, J. M. Ritter. Pharmacology, 6th
ed. Churchill Livingstone Elsevier, 2008, pp. 557-
574.
10. J. Sarko. Antidepressants, old and new: a review of
their adverse effects and toxicity in overdose,
Emerg Med Clin North Am 18: 637-654 (2000).
11. S. Kasper, I. G. Anghelescu, A. Szegedi, A. Dienel, M.
Kieser. Superior efficacy of St John's wort extract
WS 5570 compared to placebo in patients with
major depression: a randomized, double-blind,
placebo-controlled, multi-center trial.
[ISRCTN77277298] BMC Med 2000;1-13.
12. J. F. Yu, L. D. Kong, Y. Chen. Antidepressant activity
of aqueous extract of Curcuma longa in mice, J
Ethnopharmacol 83: 161-165 (2002).
13. D. Dhingra, V. Kumar. Evidences for the involvement
of monoaminergic and GABAergic systems in
antidepressant-like activity of garlic extract in mice,
Indian J Pharmacol 40: 175-179 (2008).
14. T. Sylvan. F. Runkel, Alvin. Bull (1979,
2009), Wildflowers of Iowa Woodlands, Iowa City,
Iowa: University of Iowa Press. pp. 119, Retrieved
13 December 2011.
15. T. J. Motley. The Ethnobotany of sweet flag, Acorus
calamus (Araceae), Econ Bot 48: 397-412 (1994).
16. R. Hazra, K. Ray, D. Guha. Inhibitory role of Acorus
calamus in ferric chloride-induced epileptogenesis
in rat, Hum Exp Toxicol 26: 947-953 (2007).
Anindita De et al., ARPB, 2013; Vol 3 (IV) ISSN 2250-0774
(RESEARCH ARTICLE)
525 | P a g e w w w . a r p b . i n f o
17. P. C. Dandiya, J. D. Sharma. Pharmacological actions
of asarone and β-asarone on central nervous
system, Indian J Med Res 50: 46-65 (1962).
18. P. V. Sharma. Dravyaguna–Vijnana, vol. 2,
Chaukhambha Bharti Academy, 2009, pp. 28-31.
19. K. R. Kiritikar, B. D. Basu. Indian Medicinal Plants,
2nd ed. vol. 4, International Book Distributors,
Dehradun, 1999. pp. 2626-2629.
20. A. E. Raja, M. Vijayalakshmi, G. Devalarao. Acorus
calamus linn.: chemistry and biology, Research J
Pharm Tech 2: 256-261 (2009).
21. S. R. Yende, U. N. Harle, D. T. Rajgure, T. A. Tuse, N. S.
Vyawahare. Pharmacological profile of Acorus
calamus: An Overview, Pharmacog Rev 2: 22-26
(2008).
22. S. Manikandan, R. S. Devi. Antioxidant property of α-
asarone against noise-stress-induced changes in
different regions of rat brain, Pharmacol Res 52:
467-474 (2005).
23. S. Manikandan, R. Srikumar, N. J. Parthasarathy, R. S.
Devi. Protective effect of Acorus calamus on free
radical scavengers and lipid peroxidation in
discrete regions of brain against noise stress
exposed rat, Biol Pharm Bull 28: 2327-2330 (2005).
24. K. Sairam, M. Dorababu, R. K. Goel, S. K.
Bhattacharya. Antidepressant activity of
standardized extract of Bacopamonnierain
experimental models of depression in rats,
Phytomedicine 9: 207-211(2002).
25. S. K. Bhattacharya, A. Bhattacharya, K. Sairam, S.
Ghosal. Anxiolytic-antidepressant activity of
Withania somnifera glycowithanolides: an
experimental study, Phytomedicine 7: 463-469
(2000).
26. G. K. Singh, D. Garabadu, A. V. Muruganandam, V. K.
Joshi, S. Krishnamurthy. Antidepressant activity of
Asparagus racemosus in rodent models, Pharmacol
Biochem Behav 91: 283-290 (2009).
27. L. Steru, R. Chermat, B. Thierry, P. Simon. The tail
suspension test: a new method for screening
antidepressants in mice, Psychopharmacology 85:
367-370 (1985).
28. R. D. Porsolt, A. Bertin, M. Jalfre. Behavioral despair
in mice: a primary screening test for antidepressant,
Arch Int de Pharmacodyn et de Ther 229: 327-336
(1977).
29. M. D. Shalam, S. M. Shantakumar, M. L. Narasu.
Pharmacological and biochemical evidence for the
antidepressant effect of the herbal preparation
Trans-01, Ind J Pharmacol 39: 231-234 (2007).
30. S. Loche, F. Porcelli, M. Rosen, M. Feffer, E. Stoner.
Clinical applications of the rapid high-performance
liquid chromatographic determination of serum
cortisol, J Chromatogr 317: 377-382 (1984).
31. R. D. Porsolt, G. Anton, N. Blavet, M. Jalfre.
Behavioural despair in rats: a new model sensitive
to antidepressant treatments, Eur J Pharmacol 47:
379-391 (1978).
32. C. C. Weber, G. P. Eckert, W. E. Muller. Effects of
antidepressants on the brain/plasma distribution of
corticosterone, Neuropsychopharmacology 31:
2443-2448 (2006).
33. S. K. Droste, L. D. E. Groote, H. C. Atkinson, S. L.
Lightman, J. M. H. M. Reul, A. C. E. Linthorst.
Corticosterone levels in the brain show a distinct
ultradian rhythm but a delayed response to forced
swim stress, Endocrinology 149: 3244-3253
(2008).
Thank you for copying data from http://www.arastirmax.com
